ClinicalTrials.Veeva

Menu

Effects of Inspiratory Muscle Training in Patients With Bronchiectasis

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Bronchiectasis

Treatments

Other: Inspiratory muscle training

Study type

Interventional

Funder types

Other

Identifiers

NCT00952718
CMRP-IRB-97-0458B

Details and patient eligibility

About

The purpose of this study is to determine whether inspiratory muscle training could improve and/or prevent the deterioration of inspiratory muscle strength, clinical cardiopulmonary outcome, systemic immunologic responses and quality of life in patients with bronchiectasis.

Full description

Inspiratory muscle training is reportedly beneficial in patients with diverse chronic cardio-pulmonary diseases. It can increase inspiratory muscle strength and endurance, improves exercise capacity and quality of life (QOL), and decreases the perception of dyspnea (POD) for adults with stable chronic obstructive pulmonary disease (COPD). Though the pathophysiology in COPD and bronchiectasis are different, there are some similarities in clinical presentation. In COPD patients, lung hyperinflation induces functional weakness of the inspiratory muscle and increases elastic load to breathing and intrinsic positive end expiratory pressure. Patients with bronchiectasis shows reduced ratio of FEV1/FVC, reduced FEV1, and normal or slightly reduced FVC, which indicate that airways are blocked by mucus. However, there has been no study that used IMT as a training modality to determine its effect in bronchiectasis. The clinical relevance of increased respiratory muscle strength per se by IMT alone is unknown. This study tried to evaluate the feasibility and effectiveness of home-based threshold training and examined if the effects of IMT extends to clinical outcomes such as activities of daily living and QOL in bronchiectasis patients.

Enrollment

38 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bronchiectasis confirmed by clinical history, pulmonary function test, and high resolution computed tomography

Exclusion criteria

  • Had recent exacerbation within six weeks
  • Use of corticosteroid
  • With poor consciousness level
  • Have cerebro-vascular or neuro-muscular disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

38 participants in 2 patient groups

Control
No Intervention group
Description:
No intervention.
Inspiratory muscle training
Experimental group
Description:
With intervention.
Treatment:
Other: Inspiratory muscle training

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems